Mojca Matičič
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Hepatology 39
- Hepatitis C virus research 37
- Hepatitis Viruses Studies and Epidemiology 8
- Epidemiology 38
- Hepatitis B Virus Studies 23
- Liver Disease Diagnosis and Treatment 13
- Cervical Cancer and HPV Research 4
- Co-authors
- Mario U. Mondelli (8 shared papers)Thomas Berg (3 shared papers)Markus Cornberg (2 shared papers)Tobias Boettler (2 shared papers)Philip N. Newsome (2 shared papers)Elisa Cordero (2 shared papers)Mario Poljak (25 shared papers)Jeffrey V. Lazarus (14 shared papers)
In The Last Decade
Mojca Matičič
72 papers receiving 1.5k citations
Mojca Matičič's Hit Papers
Peers
Comparison fields: 5 of 115
- Hepatology 501
- Infectious Diseases 453
- Epidemiology 553
- Microbiology 75
- Periodontics 48
Countries citing papers authored by Mojca Matičič
This map shows the geographic impact of Mojca Matičič's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mojca Matičič with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mojca Matičič more than expected).
Fields of papers citing papers by Mojca Matičič
This network shows the impact of papers produced by Mojca Matičič. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mojca Matičič. The network helps show where Mojca Matičič may publish in the future.
Co-authors
The 25 scholars most cited alongside Mojca Matičič, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 347 | |
| 2 | A multinational Delphi consensus to end the COVID-19 public health threat Hit paper breakdown → | 2022 | 128 |
| 3 | 2020 | 106 | |
| 4 | 2018 | 87 | |
| 5 | 2019 | 66 | |
| 6 | 2014 | 54 | |
| 7 | 2000 | 47 | |
| 8 | 2022 | 46 | |
| 9 | 1995 | 46 | |
| 10 | 2014 | 45 | |
| 11 | 2015 | 39 | |
| 12 | 2008 | 33 | |
| 13 | 2020 | 32 | |
| 14 | 2009 | 27 | |
| 15 | 2015 | 23 | |
| 16 | 1997 | 19 | |
| 17 | 2008 | 16 | |
| 18 | 2018 | 16 | |
| 19 | Effect of metformin and rosiglitazone on lipid metabolism in HIV infected patients receiving protease inhibitor containing HAART. | 2005 | 16 |
| 20 | 2017 | 16 |
About Mojca Matičič
Mojca Matičič is a scholar working on Hepatology, Epidemiology, Microbiology, Infectious Diseases and Virology, having authored 80 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (37 papers), Hepatitis B Virus Studies (23 papers), Liver Disease Diagnosis and Treatment (13 papers), Hepatitis Viruses Studies and Epidemiology (8 papers), Reproductive tract infections research (6 papers), HIV-related health complications and treatments (5 papers), HIV Research and Treatment (5 papers) and Cervical Cancer and HPV Research (4 papers). The work is most often cited by research in Hepatology (501 citations), Infectious Diseases (453 citations), Epidemiology (553 citations), Microbiology (75 citations) and Periodontics (48 citations). Mojca Matičič has collaborated with scholars based in Slovenia, Spain and Italy. Frequent co-authors include Mario U. Mondelli, Thomas Berg, Markus Cornberg, Tobias Boettler, Philip N. Newsome, Elisa Cordero, Mario Poljak, Jeffrey V. Lazarus, Janez Tomažič and Ludvik Vidmar. Their work appears in journals such as Journal of Hepatology, Harm Reduction Journal, BMC Infectious Diseases, Clinical Microbiology and Infection and JHEP Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.